TP-05 (lotilaner) Low Dose
TRS-018
Phase 2 small_molecule active
Quick answer
TP-05 (lotilaner) Low Dose for Lyme Disease is a Phase 2 program (small_molecule) at Tarsus Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tarsus Pharmaceuticals
- Indication
- Lyme Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active